Login / Signup

Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group.

Yassine Al TabaaOlivier CasasnovasClio BailletEmmanuel BachyEmmanuelle Nicolas-VirelizierJean Marc Schiano De ColellaClement BaillySalim KanounStéphanie GuidezEmmanuel GyanRemy GressinNadine MorineauLoic YsebaertSteven Le GouillHerve TillyHouot RochJudith TrotmanGuillaume CartronCharles Herbaux
Published in: Blood advances (2023)
Keyphrases
  • study protocol
  • phase iii
  • transcription factor
  • diffuse large b cell lymphoma
  • clinical trial
  • phase ii
  • randomized controlled trial
  • open label
  • cell therapy
  • double blind